| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ATMIN IKZF2 HIVEP1 ASH1L DVL1 DAB2 TNIP1 CHD7 RUNX1 SPAG8 ZNF467 FOXJ3 CREBBP CHUK RNASEL BRCA1 HOXD8 CDK13 TET1 MITF ELF4 SMO ASXL2 PRKDC KDM6A CDH13 PROX1 ZNF646 | 2.25e-06 | 1390 | 158 | 28 | GO:0045944 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 5.15e-06 | 124 | 158 | 8 | GO:0007229 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 1.98e-05 | 149 | 158 | 8 | GO:0010811 | |
| HumanPheno | Abnormally folded helix | 2.76e-06 | 90 | 52 | 8 | HP:0008544 | |
| HumanPheno | Overfolded helix | 1.61e-05 | 82 | 52 | 7 | HP:0000396 | |
| Pubmed | SOX5 SMG1 HIVEP1 FN1 EXPH5 ASH1L DAB2 TNIP1 PIR CREBBP NEDD9 DST CDK13 ASXL2 KDM6A BAG6 | 2.20e-08 | 591 | 163 | 16 | 15231748 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CUL4A ATMIN PRUNE2 BDP1 FRMPD2 TOM1L1 ASH1L CHD9 MDM4 FOXJ3 CREBBP SESN1 DNAH1 THAP4 FAM120C CLMN CDK13 RIN2 AKAP13 PARD3 HPS5 MCTP2 KDM6A SLC4A5 ZMAT1 | 3.21e-08 | 1489 | 163 | 25 | 28611215 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CUL4A ZSCAN5A BCORL1 CHD7 GPATCH8 RUNX1 ADAR HNRNPAB EFTUD2 THAP4 DST BRCA1 ZSCAN30 CDK13 DPY30 TONSL MITF ELF4 ASXL2 PRKDC KDM6A KIF2C | 1.89e-07 | 1294 | 163 | 22 | 30804502 |
| Pubmed | Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models. | 3.87e-07 | 32 | 163 | 5 | 27739607 | |
| Pubmed | AKAP6 SMG1 HIVEP1 FN1 ANK2 TNIP1 NEDD9 NEO1 DST CLMN DPY30 TLN1 PARD3 | 7.14e-07 | 497 | 163 | 13 | 23414517 | |
| Pubmed | HIVEP1 BCORL1 SLU7 CHD9 CHD7 RUNX1 FOXJ3 ADAR CREBBP HNRNPAB THAP4 BRCA1 CDK13 TLN1 ASXL2 PRKDC KDM6A BAG6 KIF2C | 1.14e-06 | 1103 | 163 | 19 | 34189442 | |
| Pubmed | 1.28e-06 | 225 | 163 | 9 | 12168954 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SOX5 NOL4 HIVEP1 HSPA4L BCORL1 CHD7 CREBBP PDE12 PRKDC KDM6A RAI2 | 3.11e-06 | 398 | 163 | 11 | 35016035 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 4.51e-06 | 197 | 163 | 8 | 20811636 | |
| Pubmed | Stage-dependent modes of Pax6-Sox2 epistasis regulate lens development and eye morphogenesis. | 5.56e-06 | 8 | 163 | 3 | 19666824 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 DISC1 DAB2 CHD7 MDM4 FOXJ3 NEDD9 TLN1 TONSL MITF AKAP13 | 6.48e-06 | 430 | 163 | 11 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.78e-06 | 351 | 163 | 10 | 38297188 | |
| Pubmed | 8.33e-06 | 153 | 163 | 7 | 10718198 | ||
| Pubmed | USP28 RUNX1 CREBBP HNRNPAB BRCA1 DPY30 TONSL SAGE1 PRAME CDH13 KIF2C | 1.05e-05 | 453 | 163 | 11 | 29656893 | |
| Pubmed | SMG1 HIVEP1 BCORL1 IGSF5 SLU7 CHD7 FOXJ3 CREBBP TBC1D32 DPY30 KDM6A TARBP1 FHIP2B | 1.08e-05 | 638 | 163 | 13 | 31182584 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ZNF787 CUL4A PPP1R12B DAB2 TNIP1 CPS1 ADAR HNRNPAB EFTUD2 NEDD9 DST CDK13 PRKDC MCTP2 ADGRA3 KIF2C | 1.10e-05 | 949 | 163 | 16 | 36574265 |
| Pubmed | 1.18e-05 | 107 | 163 | 6 | 11347906 | ||
| Pubmed | SOX5 SMG1 NOL4 HIVEP1 HSPA4L BCORL1 SLU7 TNIP1 R3HDM2 CHD7 GPATCH8 CREBBP DST BRCA1 DPY30 MITF ELF4 ASXL2 KDM6A RAI2 | 1.31e-05 | 1429 | 163 | 20 | 35140242 | |
| Pubmed | AKAP6 FN1 CEP162 ASH1L SLU7 CHD7 GPATCH8 FOXJ3 AREL1 CLMN TET1 ASXL2 PARD3 FERMT2 ZMAT1 FHIP2B KIF2C | 1.47e-05 | 1084 | 163 | 17 | 11544199 | |
| Pubmed | INTS6L PCSK5 LYPD6B PHACTR2 ANK2 DBNDD2 CYP24A1 TOM1L1 ASH1L GPATCH8 TNFRSF10A CPS1 SLC6A9 TONSL ELF4 CDH3 CDH13 FHIP2B | 1.74e-05 | 1215 | 163 | 18 | 15146197 | |
| Pubmed | 1.84e-05 | 313 | 163 | 9 | 20800603 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 2.16e-05 | 71 | 163 | 5 | 28319113 | |
| Pubmed | Cells redox environment modulates BRCA1 expression and DNA homologous recombination repair. | 2.18e-05 | 2 | 163 | 2 | 27771433 | |
| Pubmed | SOX5 is involved in balanced MITF regulation in human melanoma cells. | 2.18e-05 | 2 | 163 | 2 | 26927636 | |
| Pubmed | CBP/p300 as a co-factor for the Microphthalmia transcription factor. | 2.18e-05 | 2 | 163 | 2 | 9223672 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17287830 | ||
| Pubmed | Distinct roles of talin and kindlin in regulating integrin α5β1 function and trafficking. | 2.18e-05 | 2 | 163 | 2 | 22795696 | |
| Pubmed | Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis. | 2.18e-05 | 2 | 163 | 2 | 31499338 | |
| Pubmed | BRCA1 modulates the autophosphorylation status of DNA-PKcs in S phase of the cell cycle. | 2.18e-05 | 2 | 163 | 2 | 25223785 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28362255 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21484799 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 34496885 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21501420 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24390218 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 35059740 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29996118 | ||
| Pubmed | ATMIN STXBP5 R3HDM2 GPATCH8 TENM2 SYT11 STARD9 TLN1 ASXL2 TRAK2 | 2.43e-05 | 407 | 163 | 10 | 12693553 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | PHACTR2 IKZF2 HIVEP1 USP28 CEP162 DAB2 CHD9 TNFRSF10A MDM4 FOXJ3 ADAR CDK13 RIN2 TLN1 FERMT2 | 3.28e-05 | 925 | 163 | 15 | 28986522 |
| Pubmed | 4.83e-05 | 201 | 163 | 7 | 23535732 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | USP28 SLU7 TNIP1 CPS1 MDM4 FOXJ3 ADAR CREBBP CHUK TBC1D32 RNASEL DPY30 ASXL2 KIF2C | 5.59e-05 | 857 | 163 | 14 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CUL4A PHACTR2 HIVEP1 EXPH5 CEP162 MDM4 DST CLMN STARD9 SRGAP1 TET1 AKAP13 PARD3 KIF2C | 5.88e-05 | 861 | 163 | 14 | 36931259 |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 34463256 | ||
| Pubmed | RGMb controls aggregation and migration of Neogenin-positive cells in vitro and in vivo. | 6.53e-05 | 3 | 163 | 2 | 19944164 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 16417649 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 28063196 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 23626788 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 25205036 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 9632806 | ||
| Pubmed | ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. | 6.53e-05 | 3 | 163 | 2 | 19805087 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 37224811 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 24973361 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 37161136 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 9926942 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 15205472 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 30352856 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 17764108 | ||
| Pubmed | BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain. | 6.53e-05 | 3 | 163 | 2 | 18445682 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 29531217 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 22648415 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 12060406 | ||
| Pubmed | Gpr125 is a unifying hallmark of multiple mammary progenitors coupled to tumor latency. | 6.55e-05 | 17 | 163 | 3 | 35302059 | |
| Pubmed | Developmental profiling of spiral ganglion neurons reveals insights into auditory circuit assembly. | 8.36e-05 | 49 | 163 | 4 | 21795542 | |
| Pubmed | 9.05e-05 | 50 | 163 | 4 | 24449835 | ||
| Pubmed | NOL4 LYPD6B TMCO5A HIVEP1 DISC1 CYP24A1 TOM1L1 PP2D1 STARD9 SCN9A KDM6A TARBP1 | 1.02e-04 | 686 | 163 | 12 | 29987050 | |
| Pubmed | INTS6L HIVEP1 EXPH5 TOM1L1 DAB2 PLEKHA6 CREBBP DST AKAP13 PRKDC | 1.06e-04 | 486 | 163 | 10 | 20936779 | |
| Pubmed | ZNF787 ZSCAN5A BCORL1 ASH1L DTX3L CR2 THAP4 CLMN AKAP13 ASXL2 TARBP1 ZNF646 | 1.06e-04 | 689 | 163 | 12 | 36543142 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.09e-04 | 20 | 163 | 3 | 29785026 | |
| Pubmed | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. | 1.26e-04 | 21 | 163 | 3 | 20195266 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.28e-04 | 497 | 163 | 10 | 36774506 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 35240198 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 1.30e-04 | 4 | 163 | 2 | 10655477 | |
| Pubmed | Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. | 1.30e-04 | 4 | 163 | 2 | 12789342 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 21325030 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 27105579 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 19825936 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 11463834 | ||
| Pubmed | Variant mapping and mutation discovery in inbred mice using next-generation sequencing. | 1.30e-04 | 4 | 163 | 2 | 26552429 | |
| Pubmed | Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. | 1.30e-04 | 4 | 163 | 2 | 17908929 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 21914189 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 23285190 | ||
| Pubmed | Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin. | 1.30e-04 | 4 | 163 | 2 | 12867986 | |
| Pubmed | Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair. | 1.30e-04 | 4 | 163 | 2 | 20305393 | |
| Pubmed | Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation. | 1.30e-04 | 4 | 163 | 2 | 16651533 | |
| Pubmed | 1.35e-04 | 104 | 163 | 5 | 9205841 | ||
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 1.41e-04 | 56 | 163 | 4 | 9455484 | |
| Pubmed | 1.46e-04 | 22 | 163 | 3 | 36098982 | ||
| Pubmed | PCSK5 HIVEP1 DAB2 TNIP1 R3HDM2 GPATCH8 SPAG8 PCDH17 BRCA1 BAG6 RAI2 | 1.49e-04 | 608 | 163 | 11 | 16713569 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 NOL4 HIVEP1 BCORL1 ZSCAN26 CHD9 CHD7 GPATCH8 FOXJ3 BRCA1 DPY30 | 1.49e-04 | 608 | 163 | 11 | 36089195 |
| Pubmed | 1.69e-04 | 418 | 163 | 9 | 34709266 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 2.02e-04 | 178 | 163 | 6 | 27637333 | |
| Pubmed | 2.11e-04 | 529 | 163 | 10 | 14621295 | ||
| Pubmed | Regulation of planar cell polarity by Smurf ubiquitin ligases. | 2.15e-04 | 25 | 163 | 3 | 19379695 | |
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 29478807 | ||
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 12700228 | ||
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 10207087 | ||
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 36056023 | ||
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 22821713 | ||
| Pubmed | Beyond E-cadherin: roles of other cadherin superfamily members in cancer. | 2.16e-04 | 5 | 163 | 2 | 24442140 | |
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 23071553 | ||
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 14597638 | ||
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.94e-04 | 50 | 104 | 4 | 1293 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 8.92e-08 | 167 | 161 | 10 | M2995 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PMS1 HIVEP1 PEX3 CHD9 R3HDM2 RUNX1 FOXJ3 CREBBP PPM1B DST BRCA1 CDK13 UCK2 PARD3 FERMT2 | 2.07e-07 | 466 | 161 | 15 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 HIVEP1 PEX3 CHD9 R3HDM2 GPATCH8 RUNX1 FOXJ3 CREBBP PPM1B DST BRCA1 CDK13 RIN2 MITF UCK2 AKAP13 PARD3 FERMT2 ADGRA3 | 3.29e-07 | 856 | 161 | 20 | M4500 |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | 4.13e-06 | 199 | 161 | 9 | M5799 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 5.99e-06 | 157 | 161 | 8 | M7733 | |
| Coexpression | GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP | 3.11e-05 | 197 | 161 | 8 | M3307 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 3.46e-05 | 200 | 161 | 8 | M9923 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 3.46e-05 | 200 | 161 | 8 | M8632 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 3.46e-05 | 200 | 161 | 8 | M9203 | |
| Coexpression | GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 3.46e-05 | 200 | 161 | 8 | M9158 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_UP | 3.46e-05 | 200 | 161 | 8 | M5675 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ATMIN SLC25A27 IKZF2 PPP1R12B DBNDD2 ZSCAN26 DAB2 PCDH17 NEO1 TTBK1 RNASEL DST BRCA1 SYT11 CLMN SRGAP1 WDR35 KDM6A ZMAT1 | 4.94e-05 | 1102 | 161 | 19 | M2369 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 5.03e-05 | 155 | 161 | 7 | M39246 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ATMIN SLC25A27 IKZF2 PPP1R12B DBNDD2 ZSCAN26 DAB2 PCDH17 NEO1 TTBK1 RNASEL DST BRCA1 SYT11 CLMN SRGAP1 WDR35 KDM6A ZMAT1 | 6.43e-05 | 1124 | 161 | 19 | MM1070 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 7.00e-05 | 221 | 161 | 8 | M39222 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL | 1.01e-04 | 233 | 161 | 8 | M45712 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL | 1.05e-04 | 40 | 161 | 4 | M45691 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 1.05e-04 | 40 | 161 | 4 | MM17488 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL | 1.16e-04 | 304 | 161 | 9 | M45711 | |
| Coexpression | ESC_J1_UP_EARLY.V1_UP | 1.20e-04 | 178 | 161 | 7 | M2764 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 1.28e-04 | 79 | 161 | 5 | M7102 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | EPHB3 FN1 DBNDD2 ASH1L DAB2 CR2 TENM2 SESN1 NEDD9 DST MITF SORCS2 FERMT2 ADGRA3 | 1.53e-04 | 721 | 161 | 14 | M1999 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | SMG1 ANK2 HSPA4L EXPH5 PEX3 DAB2 R3HDM2 GCHFR PPM1B DST HOXD8 PARD3 | 1.67e-04 | 553 | 161 | 12 | M1475 |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP | 1.99e-04 | 136 | 161 | 6 | M1894 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 2.04e-04 | 194 | 161 | 7 | M8864 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 2.38e-04 | 199 | 161 | 7 | M5159 | |
| Coexpression | HOELZEL_NF1_TARGETS_UP | 2.42e-04 | 141 | 161 | 6 | M2142 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 2.46e-04 | 200 | 161 | 7 | M9463 | |
| Coexpression | GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP | 2.46e-04 | 200 | 161 | 7 | M5842 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN | 2.46e-04 | 200 | 161 | 7 | M9933 | |
| Coexpression | GSE30083_SP2_VS_SP4_THYMOCYTE_UP | 2.46e-04 | 200 | 161 | 7 | M5034 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 2.46e-04 | 200 | 161 | 7 | M6514 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN | 2.46e-04 | 200 | 161 | 7 | M9262 | |
| Coexpression | GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP | 2.46e-04 | 200 | 161 | 7 | M6927 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.59e-08 | 184 | 162 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.42e-08 | 190 | 162 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.58e-08 | 191 | 162 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.32e-08 | 200 | 162 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.38e-07 | 187 | 162 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 4.75e-07 | 189 | 162 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.75e-07 | 189 | 162 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.95e-07 | 190 | 162 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 5.15e-07 | 191 | 162 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.79e-07 | 194 | 162 | 8 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.79e-07 | 194 | 162 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.02e-07 | 195 | 162 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.48e-07 | 135 | 162 | 7 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.76e-07 | 198 | 162 | 8 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.28e-07 | 140 | 162 | 7 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.57e-06 | 154 | 162 | 7 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 160 | 162 | 7 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 171 | 162 | 7 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 171 | 162 | 7 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.75e-06 | 182 | 162 | 7 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.28e-06 | 185 | 162 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.51e-06 | 191 | 162 | 7 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-06 | 191 | 162 | 7 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-06 | 191 | 162 | 7 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 6.74e-06 | 192 | 162 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-06 | 192 | 162 | 7 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.74e-06 | 192 | 162 | 7 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 193 | 162 | 7 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.21e-06 | 194 | 162 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.21e-06 | 194 | 162 | 7 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.21e-06 | 194 | 162 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-06 | 195 | 162 | 7 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-06 | 198 | 162 | 7 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-06 | 198 | 162 | 7 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-06 | 198 | 162 | 7 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.51e-06 | 199 | 162 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-06 | 199 | 162 | 7 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.51e-06 | 199 | 162 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.51e-06 | 199 | 162 | 7 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.51e-06 | 199 | 162 | 7 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-06 | 199 | 162 | 7 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.51e-06 | 199 | 162 | 7 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.51e-06 | 199 | 162 | 7 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | dd68ce6934eafb75d918042fcf7fd7a750294b7f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.79e-06 | 200 | 162 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1-L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.79e-06 | 200 | 162 | 7 | 06ea96428728199a30a0f836647d6448287d3848 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-05 | 135 | 162 | 6 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.48e-05 | 158 | 162 | 6 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.48e-05 | 158 | 162 | 6 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.48e-05 | 158 | 162 | 6 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 167 | 162 | 6 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.50e-05 | 168 | 162 | 6 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 3.62e-05 | 169 | 162 | 6 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-05 | 171 | 162 | 6 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.40e-05 | 175 | 162 | 6 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 175 | 162 | 6 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 175 | 162 | 6 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 176 | 162 | 6 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.54e-05 | 176 | 162 | 6 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 176 | 162 | 6 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.69e-05 | 177 | 162 | 6 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.69e-05 | 177 | 162 | 6 | b647667da62a91dbe3890820142626e26aa779d2 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.69e-05 | 177 | 162 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.84e-05 | 178 | 162 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.84e-05 | 178 | 162 | 6 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-05 | 178 | 162 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.84e-05 | 178 | 162 | 6 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.99e-05 | 179 | 162 | 6 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-05 | 180 | 162 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 180 | 162 | 6 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-05 | 181 | 162 | 6 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-05 | 181 | 162 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 181 | 162 | 6 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 5.31e-05 | 181 | 162 | 6 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.31e-05 | 181 | 162 | 6 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.47e-05 | 182 | 162 | 6 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-05 | 182 | 162 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 182 | 162 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.47e-05 | 182 | 162 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.64e-05 | 183 | 162 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 184 | 162 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-05 | 184 | 162 | 6 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-05 | 184 | 162 | 6 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.81e-05 | 184 | 162 | 6 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.81e-05 | 184 | 162 | 6 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 184 | 162 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-05 | 184 | 162 | 6 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 184 | 162 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.99e-05 | 185 | 162 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.99e-05 | 185 | 162 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 185 | 162 | 6 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.99e-05 | 185 | 162 | 6 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.17e-05 | 186 | 162 | 6 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 186 | 162 | 6 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.36e-05 | 187 | 162 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.36e-05 | 187 | 162 | 6 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.55e-05 | 188 | 162 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-05 | 188 | 162 | 6 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-05 | 188 | 162 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.55e-05 | 188 | 162 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | FN1 CEP162 DISC1 TEX15 RUNX1 SPAG8 FOXJ3 RNASEL FAM120C GPR75 | 1.70e-06 | 199 | 162 | 10 | 6214_UP |
| Disease | Prostatic Neoplasms | PMS1 USP28 TOM1L1 ASH1L IGSF5 CHD7 TNFRSF10A RUNX1 CREBBP RNASEL BRCA1 UCK2 AKAP13 PRKDC PARD3 KDM6A CDH13 | 3.58e-08 | 616 | 157 | 17 | C0033578 |
| Disease | Malignant neoplasm of prostate | PMS1 USP28 TOM1L1 ASH1L IGSF5 CHD7 TNFRSF10A RUNX1 CREBBP RNASEL BRCA1 UCK2 AKAP13 PRKDC PARD3 KDM6A CDH13 | 3.58e-08 | 616 | 157 | 17 | C0376358 |
| Disease | eosinophil percentage of granulocytes | 3.85e-05 | 234 | 157 | 8 | EFO_0007996 | |
| Disease | ovary adenocarcinoma (is_marker_for) | 8.41e-05 | 3 | 157 | 2 | DOID:3713 (is_marker_for) | |
| Disease | systemic scleroderma | 9.31e-05 | 85 | 157 | 5 | EFO_0000717 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 9.70e-05 | 45 | 157 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | blood urea nitrogen measurement | IKZF2 CYP24A1 CHD9 R3HDM2 PLEKHA6 CPS1 AKAP13 ASXL2 HPS5 PROX1 | 1.63e-04 | 452 | 157 | 10 | EFO_0004741 |
| Disease | unipolar depression, bipolar disorder | 1.94e-04 | 156 | 157 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Adenoid Cystic Carcinoma | 2.00e-04 | 100 | 157 | 5 | C0010606 | |
| Disease | neutrophil percentage of granulocytes | 2.29e-04 | 228 | 157 | 7 | EFO_0007994 | |
| Disease | Jaw Abnormalities | 2.78e-04 | 5 | 157 | 2 | C0022360 | |
| Disease | Epidermolysis Bullosa Simplex | 2.78e-04 | 5 | 157 | 2 | C0079298 | |
| Disease | colon cancer (is_marker_for) | 2.80e-04 | 59 | 157 | 4 | DOID:219 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | IKZF2 IQCH CYP7A1 ASH1L CHD9 TNFRSF10A CPS1 TENM2 SYT11 TLN1 PCIF1 AKAP13 PARD3 PROX1 | 3.95e-04 | 914 | 157 | 14 | EFO_0004532 |
| Disease | VACTERL association (implicated_via_orthology) | 4.16e-04 | 6 | 157 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | stimulant use measurement | 4.39e-04 | 28 | 157 | 3 | EFO_0600076 | |
| Disease | cervical cancer (is_implicated_in) | 5.40e-04 | 30 | 157 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.80e-04 | 7 | 157 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | proactivator polypeptide-like 1 measurement | 5.80e-04 | 7 | 157 | 2 | EFO_0801912 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 5.80e-04 | 7 | 157 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | osteopetrosis (implicated_via_orthology) | 5.80e-04 | 7 | 157 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | Glioblastoma | 8.50e-04 | 79 | 157 | 4 | C0017636 | |
| Disease | nicotine dependence symptom count | 8.66e-04 | 285 | 157 | 7 | EFO_0009262 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.07e-04 | 139 | 157 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 9.37e-04 | 140 | 157 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 9.67e-04 | 141 | 157 | 5 | C0005684 | |
| Disease | urate measurement | NOL4 TMCO5A ASH1L R3HDM2 CPS1 ANKRD55 DNAH1 NEO1 MALRD1 SYT11 AKAP13 OTUD3 TDRD12 | 1.04e-03 | 895 | 157 | 13 | EFO_0004531 |
| Disease | Giant Cell Glioblastoma | 1.07e-03 | 84 | 157 | 4 | C0334588 | |
| Disease | response to anticonvulsant | 1.12e-03 | 85 | 157 | 4 | GO_0036277 | |
| Disease | neutrophil count | CUL4A PRUNE2 HIVEP1 STXBP5 BCORL1 ASH1L CHD9 CHD7 CPS1 ISM2 ADAR CREBBP BRCA1 MITF UCK2 AKAP13 PRKDC | 1.14e-03 | 1382 | 157 | 17 | EFO_0004833 |
| Disease | deoxycholate measurement | 1.17e-03 | 39 | 157 | 3 | EFO_0010475 | |
| Disease | photoreceptor cell layer thickness measurement | 1.20e-03 | 148 | 157 | 5 | EFO_0803370 | |
| Disease | Congenital small ears | 1.36e-03 | 41 | 157 | 3 | C0152423 | |
| Disease | non-high density lipoprotein cholesterol measurement | PCSK5 HIVEP1 FN1 CYP7A1 R3HDM2 CHD7 DTX3L MITF PCIF1 SORCS2 TRAK2 | 1.57e-03 | 713 | 157 | 11 | EFO_0005689 |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.78e-03 | 45 | 157 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | urate measurement, bone density | AKAP6 RUNX1 TENM2 PCDH17 DNAH1 NEDD9 THAP4 PRKDC TEX44 CDH13 | 1.83e-03 | 619 | 157 | 10 | EFO_0003923, EFO_0004531 |
| Disease | basophil count, eosinophil count | 1.89e-03 | 241 | 157 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | phosphocreatine measurement | 2.11e-03 | 13 | 157 | 2 | EFO_0010521 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.15e-03 | 169 | 157 | 5 | DOID:3908 (is_marker_for) | |
| Disease | JT interval | 2.18e-03 | 248 | 157 | 6 | EFO_0007885 | |
| Disease | vitamin D measurement | 2.22e-03 | 336 | 157 | 7 | EFO_0004631 | |
| Disease | mean corpuscular hemoglobin concentration | CUL4A ATMIN SOX5 HSPA4L CPS1 RUNX1 PPM1B SLC6A9 NEO1 PCIF1 AKAP13 ASXL2 PRKDC CA1 | 2.40e-03 | 1105 | 157 | 14 | EFO_0004528 |
| Disease | Medulloblastoma | 2.41e-03 | 50 | 157 | 3 | C0025149 | |
| Disease | QRS amplitude, QRS complex | 2.41e-03 | 50 | 157 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | Pneumoconiosis | 2.45e-03 | 14 | 157 | 2 | C0032273 | |
| Disease | Bagassosis | 2.45e-03 | 14 | 157 | 2 | C0004681 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 2.45e-03 | 14 | 157 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 2.45e-03 | 14 | 157 | 2 | DOID:7474 (is_marker_for) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.82e-03 | 15 | 157 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.82e-03 | 15 | 157 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.82e-03 | 15 | 157 | 2 | C0154091 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 2.82e-03 | 15 | 157 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | response to olanzapine | 2.82e-03 | 15 | 157 | 2 | GO_0097333 | |
| Disease | health literacy measurement | 2.85e-03 | 53 | 157 | 3 | EFO_0010104 | |
| Disease | total blood protein measurement | 2.88e-03 | 449 | 157 | 8 | EFO_0004536 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.89e-03 | 181 | 157 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Glioblastoma Multiforme | 2.97e-03 | 111 | 157 | 4 | C1621958 | |
| Disease | hematocrit | SOX5 HIVEP1 BCORL1 ASH1L R3HDM2 PLEKHA6 RUNX1 MITF ASXL2 TRMT61B CCDC157 PROX1 TDRD12 | 3.02e-03 | 1011 | 157 | 13 | EFO_0004348 |
| Disease | breast cancer (is_marker_for) | 3.18e-03 | 185 | 157 | 5 | DOID:1612 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 3.21e-03 | 16 | 157 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | dental caries | 3.32e-03 | 187 | 157 | 5 | EFO_0003819 | |
| Disease | response to statin | 3.33e-03 | 56 | 157 | 3 | GO_0036273 | |
| Disease | neuroticism measurement, cognitive function measurement | 3.41e-03 | 566 | 157 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.50e-03 | 57 | 157 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 3.59e-03 | 117 | 157 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | creatinine measurement, glomerular filtration rate | 3.59e-03 | 117 | 157 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | serum urea measurement | 3.97e-03 | 195 | 157 | 5 | EFO_0009795 | |
| Disease | free androgen index | 4.00e-03 | 374 | 157 | 7 | EFO_0007005 | |
| Disease | sphingosine 1-phosphate measurement | 4.07e-03 | 18 | 157 | 2 | EFO_0800185 | |
| Disease | Carcinoma of bladder | 4.07e-03 | 18 | 157 | 2 | C0699885 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 4.24e-03 | 61 | 157 | 3 | C1961102 | |
| Disease | stroke, major depressive disorder | 4.53e-03 | 19 | 157 | 2 | EFO_0000712, MONDO_0002009 | |
| Disease | Osteoporosis | 4.65e-03 | 63 | 157 | 3 | C0029456 | |
| Disease | multiple sclerosis | 4.66e-03 | 594 | 157 | 9 | MONDO_0005301 | |
| Disease | Malignant neoplasm of breast | AKAP6 FN1 ANK2 PPP1R12B CYP24A1 BCORL1 TNIP1 DTX3L MDM4 ADAR BRCA1 FKBPL ZNF646 | 4.99e-03 | 1074 | 157 | 13 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AHGLPVMDDQTQGSD | 181 | Q9BT88 | |
| MNPVEKEHTSQNNEG | 196 | Q8N6Q1 | |
| QHMVQGESETADVSP | 1511 | Q5RHP9 | |
| MQENNEQTDTLPSQH | 1476 | A6H8Y1 | |
| MTTSEHIQDEPGTND | 1966 | A6H8Y1 | |
| EHRSSEQPQVSMDTG | 1491 | Q9NR48 | |
| ESGPQNRFELSMNEH | 356 | Q96JP9 | |
| ASSHEQPASGLMQQT | 71 | Q14511 | |
| NMNSSEESPTGAHII | 571 | Q96NH3 | |
| SDPHISMQVQENGEI | 146 | Q13410 | |
| PSDGSAVDVHINMEQ | 141 | P46379 | |
| PQLDNSLTEHSMDND | 1136 | Q8IWK6 | |
| MSATGDRHPTQGDQE | 1 | P0C2W7 | |
| MNQGPEESESHLCSD | 946 | Q5H9F3 | |
| EEDVMPHQNSETNSS | 626 | Q12802 | |
| MASSIDQGHLGNPEQ | 2391 | Q92793 | |
| NISEINHQDNEGMTP | 151 | Q3KP44 | |
| FEIHTNPQTNEGMLS | 411 | P55290 | |
| HNTMGTSPCEAELQE | 6 | Q05D60 | |
| PTDSGNVTDHMERQV | 571 | Q569K6 | |
| ETHNAESPDFQLQAM | 1271 | Q9P2D1 | |
| TQQASGDDTHTPLRM | 421 | Q9NRI5 | |
| TPVSGQDDLIQHQDM | 1226 | Q14004 | |
| SSDMDHNSAVPGSQV | 1336 | Q76L83 | |
| PLNNHMISQADDLSN | 426 | Q9Y2K5 | |
| NHPSGEVKAENNIEM | 416 | Q9Y5P3 | |
| SSEMGAVLEQLDHPN | 1111 | O14917 | |
| MAQNTENHDPVGSIL | 1 | Q86VS3 | |
| QDEDSLHSVPVAQMG | 541 | Q5JSJ4 | |
| EEIPASDAQLNSQMG | 3191 | Q01484 | |
| IVRGQTEESMNESHP | 226 | Q9Y5S8 | |
| MSATGDRHPTQGDQE | 1 | Q5JQC4 | |
| MSNEVETSATNGQPD | 1 | P98082 | |
| SMTSQHFEEQSVPGE | 166 | Q6DN12 | |
| EDPDHLNQSSSPSQM | 171 | P13378 | |
| MDSLAAGELNASHQP | 1 | Q8N8D9 | |
| ALAQDHSMDIPSQDQ | 121 | O15151 | |
| TPMDGETFSQHLQAV | 1896 | Q38SD2 | |
| SNGMDDDIHQLEDPS | 16 | Q99607 | |
| STHPDAMNQQLETAQ | 4766 | Q03001 | |
| STIIHEANEEQGNSM | 721 | O15111 | |
| GNEDNVSHAPVMFET | 501 | Q9UPZ3 | |
| LHTINGEGMEESQSP | 851 | O15550 | |
| ASEQMDGDNTTHPKN | 416 | Q9UKJ3 | |
| EAMDSPVSLQDEHQG | 436 | Q6H9L7 | |
| DNTHPCQSDMNIEGA | 141 | Q92824 | |
| GAQALNSHMPAETEE | 221 | Q86V87 | |
| ADGSHKNMQRDQSEP | 56 | Q6L8Q7 | |
| PTEQDLQHGNSMNSL | 301 | P56589 | |
| IQHGPFVMNTNEEIS | 251 | O00625 | |
| SEASIMGQFDHPNII | 681 | P54753 | |
| DSMVVSHGNETQLTP | 561 | Q8NEV8 | |
| PGAIDSNNSLSEMTH | 841 | P00451 | |
| THLSLSMNPVEDNGV | 1011 | P59047 | |
| ENSNGHMIPIGEEST | 96 | O75167 | |
| ETADSHENNMDGPIS | 371 | Q9UKS7 | |
| MNSTGHLQDAPNATS | 1 | O95800 | |
| GPQENVHMFVDSDST | 251 | Q8IV76 | |
| DNSEAPAHLQTDFQM | 191 | Q5T2D3 | |
| EDGLCHMTQDQSLQP | 76 | Q5VYJ5 | |
| DNLEQPMGSSHASQV | 1131 | P38398 | |
| DCMPSDGQHVISEQS | 396 | Q9P2D7 | |
| VNDQTNEGIMHESKP | 356 | P31327 | |
| SGIESPTDDHVQMDQ | 496 | O43313 | |
| SSDEISDAEQMPQHT | 611 | Q3L8U1 | |
| HGSTSQMPEALQASD | 81 | Q9UIM3 | |
| SEMIIHNVEPSDSGN | 106 | Q9NSI5 | |
| MANENHGSPREEASL | 1 | Q9H4Z3 | |
| MLEGSPQSQCQSDHQ | 946 | P20023 | |
| HGEATNSMASDNQPE | 681 | P55265 | |
| QATDNEPVEMLHSGT | 486 | Q07973 | |
| QSQAETPSGDMHQHE | 106 | Q8TDB6 | |
| DEQSDPELMQHLGAS | 21 | P30047 | |
| TPQSSGMDNHLEELS | 186 | Q9BQY9 | |
| LHDDMESQPLIGTQS | 1796 | P02751 | |
| QGLMNIPSESSQQSH | 311 | Q9UPW0 | |
| LSNVEGDNAVPMQHN | 231 | P00915 | |
| QGQSEDEQPDASQMH | 91 | Q68DX3 | |
| SPSGQQELFSSHVMQ | 21 | Q5JV73 | |
| HMQNQSDSGPIDLTV | 511 | Q13619 | |
| GESHAFSEDPMLQNS | 476 | Q9NX05 | |
| DNPTNNSMSLRDEHN | 196 | O15033 | |
| HPQENEENSKNISTM | 326 | Q5TB80 | |
| TEDPDLQVSAMQHQT | 431 | P05155 | |
| TITHELQGMAPSDQA | 141 | A6NNW6 | |
| QEQDSGNHPTMAESL | 131 | Q9ULL0 | |
| HRSIDPMDGNTTENI | 111 | P22680 | |
| HPNVASSRDGMDNET | 121 | O14640 | |
| MLEGQTQVAENPHSE | 6 | Q9C005 | |
| EESSGTPAHQMNLRG | 411 | Q96AC1 | |
| EDTDVANGVMNGHTP | 156 | Q9BRL7 | |
| HPQEESEESNVSMAS | 306 | P05060 | |
| HSGPSGEQLIQMETE | 591 | Q99661 | |
| SVIPFQNDMHNDESG | 386 | P54277 | |
| HAVSENGASVEDPMN | 186 | P22223 | |
| ASDQPSHSLERQMNG | 966 | Q8TEW0 | |
| NTNETITMPHAGVED | 151 | Q9ULK6 | |
| VEAEGSHSNSPTNMA | 426 | Q01196 | |
| EEQPMETTGATENGH | 6 | Q99729 | |
| ITNGNHSVDEMPVNS | 246 | Q9Y6P5 | |
| TNHLDQVPSMQDGSE | 291 | Q99932 | |
| AILMENTPGSENHED | 221 | O75674 | |
| SHMGDEVCQVSAQQP | 336 | Q7Z6B7 | |
| QTGMSADNLQPKDTH | 1416 | Q8WUY3 | |
| EGDVMHLSQSPSVSQ | 336 | P78395 | |
| MEDSHGVNFPAQSLQ | 256 | Q587J7 | |
| MSHSPSVALRGNENE | 176 | Q92786 | |
| NPMEASETVHLANGV | 2836 | Q96Q15 | |
| DITPVDNSMDSNIHQ | 1196 | Q92859 | |
| QEMTSPVSHSEDVQG | 1121 | Q96PQ0 | |
| MESRDHNNPQEGPTS | 1 | Q05823 | |
| MEDSDGQSFIHNPSL | 1071 | Q15858 | |
| SPNLSDGTVLSMNHN | 581 | Q9H156 | |
| DGTVLSMNHNTDTPR | 586 | Q9H156 | |
| LDSNTSHQIMDTNPD | 201 | Q9NT68 | |
| SHQIMDTNPDEEFSP | 206 | Q9NT68 | |
| SDAGNPVTMQESHTE | 441 | O75688 | |
| PDMTQQGSSEASHNS | 1446 | Q9P2P6 | |
| GSSSPHNSDDEQKMN | 716 | Q5T5C0 | |
| MQSPQNLHGQQDDDS | 246 | O94818 | |
| KHSENDSVPMQDTQV | 151 | Q8NFU7 | |
| IDMIDNDQGSSSPSN | 581 | O00327 | |
| SNLETEHLDPQMGDA | 1391 | Q13023 | |
| DPMDSHQSQESPNLE | 831 | Q96JQ2 | |
| APSAELQSTQHMEAQ | 151 | Q53QW1 | |
| LQSTQHMEAQPVESD | 156 | Q53QW1 | |
| EEQNSPESSSHANAM | 131 | Q15025 | |
| SPTGEENLMNSNHRD | 11 | O60296 | |
| ATTNSDIPNHNMVSE | 11 | Q9Y2H5 | |
| NLENGLEPAETHSMV | 41 | Q8WYP3 | |
| FTPHAEMDLGQLSSQ | 341 | Q9BU70 | |
| SQPAQMLSVDTGHAD | 491 | Q5TCY1 | |
| HLNSNEMPEDSSTPE | 331 | Q9Y397 | |
| QSQKDERNGHEASMP | 116 | Q96N58 | |
| EEPRQQDTTHGQEMF | 131 | Q86W11 | |
| HQGSEDPSMLSQAQS | 116 | Q9BVS5 | |
| EQNRAESECPGMNTH | 201 | O75030 | |
| VHEEKMTNGQQAPDN | 676 | Q9NXZ1 | |
| QNLEGDHSDAPMETE | 501 | O95757 | |
| GESDTDPHFQDALMQ | 656 | Q9Y490 | |
| EMLLQAAASGQDPHS | 661 | Q96HA7 | |
| MASSETQLGNHDVDP | 26 | Q9BUG6 | |
| HTDESSQDQLPSAQM | 336 | O15015 | |
| NTPLEDNIMTHGLSS | 221 | O95847 | |
| QHSLAMAQNGAVPSE | 76 | P48067 | |
| MESVQSDPQNGIHCI | 1111 | Q9BY07 | |
| GEEEPNSQMEKDHNS | 221 | O95391 | |
| EQSEAVATEAQGMPH | 181 | A0A0J9YWL9 | |
| VATEAQGMPHSEAQV | 186 | A0A0J9YWL9 | |
| MAGDSEQTLQNHQQP | 1 | Q9BZX2 | |
| TNDDHSVTEGINVMN | 966 | Q96RU2 | |
| QNPGQELSFSMHTVS | 581 | Q99835 | |
| SEQQMESQEPADLTG | 311 | O00220 | |
| LGEVHPSEMINNAEN | 181 | P78527 | |
| SEPMEAHNEGSNLER | 206 | Q16670 | |
| RTPTSQHNTMEVDGN | 81 | P35711 | |
| RGSVSSELENHPMNE | 411 | Q13342 | |
| ASIQHLQEMDSGQEP | 786 | Q13395 | |
| SATMPALSLNNDDHQ | 606 | Q9BXT5 | |
| NIMDTPGHVNFSDEV | 201 | Q15029 | |
| AAPSNLSMNQTLEGH | 56 | Q9P2L0 | |
| LETNENSHQKGDMNP | 616 | P15822 | |
| VQSEHSDASPMSINE | 316 | Q8WY91 | |
| PREGSHNAQEQMSSS | 26 | Q7Z7K2 | |
| QLMEEHDQASPSGFQ | 151 | Q5H9K5 | |
| NTHDGLAESSPSQEM | 336 | A8MPX8 | |
| GPLDSEDQQMASHEN | 11 | Q6DD87 | |
| EGMICNVELPTNHTN | 136 | Q8NI32 | |
| SEHNTEFLNVPDQGM | 1001 | O00160 | |
| GSHNMLSEVANSREP | 446 | O60237 |